Nuclear Medicine Equipment Market By Product (Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET)), By Application (Oncology, Neurology, Cardiology, Other Applications), By End User (Hospitals, Imaging Centers, Academic and Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2030
Nuclear medicine equipment utilizes radioactive substances, which are introduced into the body either intravenously or orally in small quantities, to diagnose and treat various diseases. This equipment provides images by capturing the radiation from these radioactive medicines. This technique is used for the early diagnosis of a disease, as it tracks the molecular activities within the body. In addition, it is used to examine the immediate response to therapeutic interventions
The key factors that drives the growth of the market are an increase in the prevalence of cancer, heart-related diseases, and neurological disorders has increased the importance of early disease diagnosis, which is expected to positively impact the market growth. The growth of the nuclear medicine equipment market is driven by the availability of high-quality equipment, rise in the adoption of nuclear medicine equipment, and the emergence of innovative & advanced equipment. However, high cost of this equipment and their short half-life, high hospital expense, and high cost related to diagnostic imaging services hinder the market growth. In addition, the key players in the industry have adopted product launch as their key developmental strategy to expand their market foothold. For instance, in November 2016, Philips launched an advanced visual analysis and quantification platform called IntelliSpace Portal 9.0., which assisted radiologists to diagnose and monitor the treatment of neurological diseases, such as multiple sclerosis and dementia.
The nuclear medicine equipment market is segmented on the basis of product type , application, end user, and region. Depending on product, the market is bifurcated into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). SPECT segment is fragmented into standalone and hybrid SPECT, while PET into standalone and hybrid PET. By application, the market is categorized into cardiology, neurology, oncology, and others. By end user, it is classified into hospitals, imaging centers, and academic & research institutes. Region-wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, Republic of South Africa, Argentina, and rest of LAMEA).
The key players in the global nuclear medicine equipment market include General Electric Company, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Digirad Corporation, Mediso Medical Imaging Systems, Ltd., Toshiba Corporation, Bozlu Holding, Neusoft Corporation, Compañía Mexicana de Radiología CGR, S.A de C.V., and SurgicEye GmbH.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nuclear medicine equipment market analysis from 2020 to 2030 to identify the prevailing nuclear medicine equipment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the nuclear medicine equipment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global nuclear medicine equipment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
Single-Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
By End User
Academic and Research Institutes
Rest of Europe
Rest Of Asia Pacific
Rest of LAMEA
Key Market Players
Mediso Medical Imaging Systems
General Electric Company
Koninklijke Philips N.V.
Nuerosoft Medical Systems
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook